🇺🇸 FDA

Company profile · Sponsor

Acrivon

Acrivon Therapeutics

ACRV · NYSE pharma WATERTOWN, MA, USA
Pipeline
4
Drugs
0
Patents
0

Quick answer

Acrivon (ACRV) is a pharma company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ACRV
Exchange NYSE
Company type pharma
Headquarters WATERTOWN, MA, USA
SEC CIK 0001781174

Pipeline (4)

Search pipeline →

  1. ACR-368

    Acrivon

    Endometrial Adenocarcinoma

    phase 2 small molecule active

    1 trial

  2. GEMZAR 200 mg, poudre pour solution pour perfusion, ACR-368

    Acrivon

    Endometrial cancer

    phase 2 small molecule active

    1 trial

  3. Gemcitabine

    Acrivon

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  4. ACR-2316

    Acrivon

    Specific Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Acrivon?

Acrivon (ACRV) is a pharma company. headquartered in WATERTOWN, MA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Acrivon sponsor?

We track 4 ClinicalTrials.gov-linked programs for Acrivon, including ACR-368 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Acrivon company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.